Table 4.
CAR T-cell outcomes | Patients N = 280 |
---|---|
Follow up time, median days (range) | 218 (7-1340) |
Disease progression, n (%) | 122 (44) |
Days to progression, median (range) | 83 (7-742) |
Death, n (%) | 68 (24) |
Days to death, median (range) | 150 (7-664) |
ANC <1000 after d 30 | 116 (41) |
IgG <400 after d 30 | 99 (35) |
IVIG administration after d 30 | 111 (40) |
CD4 T-cell count <200 after d 30 | 55 (20) |
IVIG, IV immunoglobulin G.